Roughly one in three US adults reports getting less than seven hours of sleep on a regular basis, according to the CDC. The American Academy of Sleep Medicine recommends at least seven hours for adults. Globally, a 2019 estimate published in The Lancet Respiratory Medicine put obstructive sleep apnea at nearly 1 billion adults aged 30 to 69. Most of those people have never been diagnosed.
That gap between need and care has created a crowded market of sleep tech companies. Smart rings, watches, bed sensors, respiratory devices and digital therapy apps now turn nighttime data into scores, charts and coaching. Some products are regulated medical devices. Others are wellness gadgets that estimate sleep stages from heart rate and motion.
The difference between tracking and diagnosing is central. A wearable can show trends in sleep duration, resting heart rate and temperature. Only a clinical evaluation, often with polysomnography or an approved home sleep apnea test, can diagnose a sleep disorder. The 20 companies below were chosen for active products, documented technology and relevance to sleep health. They represent different categories, and company size or popularity does not prove clinical effectiveness.
How Sleep Technology Is Changing Sleep Health
Sleep measurement began in laboratories. Polysomnography records brain waves, eye movement, muscle tone, breathing, oxygen levels and heart rhythm overnight, and a trained technologist scores the data. It remains the reference standard. Actigraphy, a wrist-worn motion sensor, arrived later and estimates sleep and wake from movement.
Consumer devices expanded on actigraphy. Modern wearables add photoplethysmography, an optical sensor that reads pulse, along with skin temperature, accelerometers and sometimes blood oxygen. Contactless systems, including under-mattress sensors, use ballistocardiography to detect heartbeat, breathing and movement through the bed.
Artificial intelligence now sits on top of these signals. Machine learning models estimate sleep stages, detect breathing disturbances and personalize recommendations. The quality of those models depends on training data, validation against polysomnography and the population tested. A model trained mostly on young, healthy adults may perform less well in older adults or people with sleep disorders.
Consumer Sleep Tracking Versus Clinical Sleep Diagnostics
Independent studies generally find that consumer wearables do reasonably well at separating sleep from wake, and total sleep time estimates are often close. They are weaker at identifying sleep stages. Agreement with polysomnography for light, deep and REM sleep is moderate at best, and errors rise in people with fragmented sleep.
For that reason, consumer sleep stage numbers should not be treated as medical diagnoses. Clinical devices are built for a defined intended use, validated against polysomnography and cleared by regulators such as the FDA. A consumer device may offer a screening notification, but a positive result requires clinical confirmation.
| Technology | Physiological measurements | Clinical role | Regulatory status | Limitations |
|---|---|---|---|---|
| Polysomnography | EEG, EOG, EMG, airflow, oxygen, ECG | Diagnostic reference standard | Regulated medical devices | Cost, lab setting |
| Home sleep apnea test | Airflow, effort, oxygen, sometimes pulse signals | Diagnoses obstructive sleep apnea | FDA-cleared devices | Misses non-apnea disorders |
| Consumer wearable | Pulse, motion, temperature | Wellness tracking | Mostly unregulated, some features cleared | Stage accuracy limited |
| Under-mattress sensor | Heart rate, breathing, movement | Tracking, some cleared uses | Varies | Shared beds, signal noise |
| Digital CBT-I app | Self-reported sleep diary | Treatment for insomnia | Some FDA-cleared | Needs user engagement |
Major Segments of the Global Sleep Tech Market
The market divides into six segments. Wearables, including rings and watches, target consumers and increasingly employers and health plans. Connected mattresses and bed systems sell comfort and sleep tracking. Respiratory devices, led by CPAP therapy, treat sleep apnea. Diagnostic companies make home and laboratory testing equipment. Oral appliances treat mild to moderate apnea. Digital therapeutics deliver cognitive behavioral therapy for insomnia.
Business models differ. Wearable brands sell hardware and, in some cases, subscriptions. Respiratory companies earn recurring revenue from masks and supplies. Diagnostic firms sell to sleep labs and physicians. Digital therapeutics firms contract with health plans, employers and health systems.
20 Global Sleep Tech Companies and Their Innovations
The profiles are grouped by category. Where companies have merged or been acquired, they are listed once under the current owner.
Wearables and Consumer Platforms
1. Oura (Oulu, Finland, and San Francisco, US).
Oura makes a smart ring that tracks sleep, heart rate variability, temperature and activity. The ring measures through pulse and skin temperature sensors and provides a readiness score. The company has reported selling several million rings and raised funding at a valuation above $10 billion in 2025. It is a wellness product, and its sleep stage estimates are algorithmic. Subscription fees apply for full features.
2. WHOOP (Boston, US).
WHOOP offers a wrist or body-worn band and membership that scores recovery, sleep and strain. It focuses on athletes and performance users. The company has drawn regulatory attention over its blood pressure feature, which the FDA questioned in 2025, so consumers should treat health features as wellness unless cleared.
3. Withings (Issy-les-Moulineaux, France).
Withings sells connected scales, watches and the Sleep Analyzer, a mat placed under the mattress. The device tracks sleep and breathing disturbances and has received FDA clearance for sleep apnea detection in certain versions. Withings is notable for blending wellness and cleared medical products.
4. Garmin (Olathe, Kansas, US).
Garmin integrates sleep tracking into its watches and offers a dedicated armband sleep monitor. It reports sleep stages, a sleep score and body battery. These are consumer estimates, not diagnoses.
5. Apple (Cupertino, California, US).
Apple Watch tracks sleep stages and, since 2024, offers a sleep apnea notification feature authorized by the FDA. The feature screens for signs of moderate to severe sleep apnea and prompts users to seek evaluation. It does not diagnose and is not intended for people already diagnosed.
6. Samsung (Suwon, South Korea).
Samsung’s Galaxy Watch tracks sleep and received De Novo authorization for a sleep apnea feature in 2024. Samsung Health also provides sleep coaching and, with the Galaxy Ring, ring-based tracking.
7. Fitbit (San Francisco, US, owned by Google).
Google acquired Fitbit in 2021. Fitbit devices estimate sleep stages and provide a sleep score. Its large user base has supported research on sleep patterns, though individual accuracy varies.
Smart Sleep Environments
8. Eight Sleep (New York, US).
Eight Sleep sells the Pod, a mattress cover with temperature control and embedded sensors. It heats and cools each side of the bed and tracks sleep and heart rate. Temperature regulation may improve comfort, but clinical sleep benefits have not been established through large independent trials.
9. Sleep Number (Minneapolis, Minnesota, US).
Sleep Number makes adjustable air beds with sensors that estimate sleep, heart rate and breathing. Its SleepIQ platform provides scores and suggestions. The company has faced business challenges in recent years, so product availability should be confirmed.
10. Emma Sleep (Frankfurt, Germany).
Emma sells mattresses and sleep products across Europe and other regions. It is mainly a consumer bedding brand. Its relevance to sleep tech lies in product design, since it does not provide clinical sleep diagnostics.
11. Happiest Baby (Los Angeles, US).
Happiest Baby makes the SNOO Smart Sleeper, a bassinet that responds to infant fussing with motion and sound and keeps babies on their backs. The FDA authorized SNOO through its De Novo pathway in 2023. Caregivers should still follow safe sleep guidance from pediatric authorities.
Respiratory and Sleep Apnea Care
12. ResMed (San Diego, US).
ResMed is a leading maker of CPAP devices, masks and cloud software. Its AirSense devices transmit usage and mask-leak data for clinicians and patients. The company also expanded into home sleep testing. CPAP is the standard therapy for obstructive sleep apnea, though adherence is a persistent problem.
13. Philips (Amsterdam, Netherlands).
Philips was a major sleep and respiratory device maker. After a 2021 recall of DreamStation devices, a 2024 consent decree limited new US sales of certain sleep and respiratory devices until conditions are met. The case is a reminder that large companies and clinical devices carry safety risk.
14. Fisher and Paykel Healthcare (Auckland, New Zealand).
Fisher and Paykel makes CPAP masks and humidification systems. It is known for mask design that targets comfort and fit. Mask fit is a major driver of CPAP adherence.
15. SomnoMed (Sydney, Australia).
SomnoMed produces custom mandibular advancement devices that reposition the jaw to keep the airway open. They are an alternative for mild to moderate sleep apnea or CPAP intolerance, and dentists typically fit them.
Clinical Diagnostics
16. Nox Medical (Reykjavik, Iceland).
Nox Medical makes polysomnography and home sleep testing systems used by sleep labs and clinics. Its products are clinical tools, not consumer devices.
17. ZOLL Itamar (Caesarea, Israel, owned by ZOLL, an Asahi Kasei company).
ZOLL acquired Itamar Medical in 2021. The WatchPAT is a wrist-worn home sleep apnea test that uses peripheral arterial tone, oximetry and actigraphy. The earlier outline listed Itamar and ZOLL separately, but they are one product line here.
18. SleepImage (Rochester, New York, US).
SleepImage offers a finger-worn ring and software that analyze cardiopulmonary coupling to assess sleep quality and apnea risk. The system has FDA clearance for specific uses and is used by clinicians.
Digital Therapeutics and Neuromodulation
19. Big Health (San Francisco, US, and London, UK).
Big Health developed Sleepio, a digital cognitive behavioral therapy program for insomnia. A prescription version, SleepioRx, received FDA clearance in 2024. This replaced a duplicate in the candidate list. The program has randomized trial evidence.
20. Neurovalens (Belfast, Northern Ireland).
Neurovalens makes Modius Sleep, a headset that delivers mild electrical stimulation through vestibular pathways. The device received FDA clearance for insomnia. Independent evidence is still limited compared with CBT-I.
| Company | Headquarters | Technology category | Flagship offering | Target users |
|---|---|---|---|---|
| Oura | Finland, US | Wearable | Oura Ring | Consumers |
| WHOOP | Boston | Wearable | WHOOP band | Athletes, consumers |
| Withings | France | Wearable, under-mattress | Sleep Analyzer | Consumers, clinicians |
| Garmin | Kansas | Wearable | Watches, Index Sleep Monitor | Consumers |
| Apple | California | Wearable | Apple Watch sleep apnea notifications | Consumers |
| Samsung | South Korea | Wearable | Galaxy Watch, Ring | Consumers |
| Fitbit | San Francisco | Wearable | Fitbit devices | Consumers |
| Eight Sleep | New York | Smart bed | Pod | Consumers |
| Sleep Number | Minnesota | Smart bed | SleepIQ beds | Consumers |
| Emma Sleep | Germany | Mattress | Emma mattresses | Consumers |
| Happiest Baby | Los Angeles | Infant sleep | SNOO | Parents |
| ResMed | San Diego | Respiratory | AirSense CPAP | Patients |
| Philips | Netherlands | Respiratory | DreamStation (limited US sales) | Patients |
| Fisher and Paykel | New Zealand | Respiratory | CPAP masks | Patients |
| SomnoMed | Australia | Oral appliance | SomnoDent | Patients |
| Nox Medical | Iceland | Diagnostics | Nox PSG systems | Clinicians |
| ZOLL Itamar | Israel | Diagnostics | WatchPAT | Clinicians |
| SleepImage | New York | Diagnostics | SleepImage Ring | Clinicians |
| Big Health | US, UK | Digital therapeutics | Sleepio, SleepioRx | Insomnia patients |
| Neurovalens | Northern Ireland | Neuromodulation | Modius Sleep | Insomnia users |
Comparing Sleep Tech Products, Sensors and Capabilities
Sensor placement affects data quality. Wrist devices are convenient but move constantly and can lose signal. Rings sit on the finger, where pulse signals are strong and motion is smaller, which may improve heart rate variability measurement. Contactless sensors avoid wearing anything but struggle when two people share a bed. Clinical systems attach multiple sensors to the body and measure far more signals.
Battery life, comfort and ecosystem integration shape daily use. Rings often last several days per charge, while watches usually require daily or near-daily charging, which can interrupt overnight wear. Data privacy also differs, because some brands share data with third parties and others offer strict controls.
| Wearable type | Sensors | Measurements | Strengths | Limitations | Intended use |
|---|---|---|---|---|---|
| Wrist | PPG, accelerometer, temperature | Sleep time, stages, heart rate | Widely available, multi-function | Motion noise, battery | Wellness, some screening |
| Ring | PPG, temperature, accelerometer | HRV, temperature, sleep | Comfortable, long battery | Fit, cost | Wellness |
| Contactless | Ballistocardiography, radar | Breathing, heart rate | No wear needed | Shared beds | Wellness, some cleared uses |
| Clinical | EEG, airflow, oxygen, ECG | Full physiological data | Gold standard | Cost, access | Diagnosis |
AI Powered Sleep Insights and Personalization
Algorithms estimate sleep stages from motion and pulse patterns, then compare nights against personal baselines. Trend analysis can flag late bedtimes, irregular schedules or elevated resting heart rate. Coaching features suggest consistent sleep times or earlier caffeine cutoffs.
Transparency is limited. Companies rarely publish full training data or error rates. Overinterpretation is a real risk. People may chase a perfect sleep score and develop orthosomnia, a condition in which worry about tracker data worsens sleep. Recommendations should be treated as prompts for good habits, not medical advice.
Smart Mattresses and Connected Sleep Environments
Temperature matters for sleep, since core body temperature falls at sleep onset. Cooling surfaces may help some people feel more comfortable. Adjustable bases can reduce snoring for some sleepers by raising the head.
Still, the distinction between comfort and clinical benefit is essential. Few smart beds have large, independent trials showing improved sleep disorders. A better night in a cooler bed is a fair claim. Treating sleep apnea or insomnia is not.
Clinical Applications in Sleep Disorders
Sleep apnea is the main clinical target. Consumer notifications from Apple and Samsung screen for risk. Home sleep apnea tests such as WatchPAT confirm diagnosis in suitable patients. CPAP then treats the condition, and connected devices help clinicians monitor adherence. Oral appliances serve some patients.
Insomnia has a strong non-drug treatment. Cognitive behavioral therapy for insomnia is recommended as first-line care by the American College of Physicians. Digital CBT-I programs such as Sleepio have shown improvement in insomnia severity in randomized trials, and meta-analyses support their use. Effects depend on engagement.
Formal evaluation is needed for loud snoring with pauses in breathing, excessive daytime sleepiness, sleep-related injuries, sleepwalking, restless legs, or insomnia that lasts more than a few weeks. Drowsy driving is an urgent warning sign.
| Intervention | Target condition | Study design | Measured outcome | Evidence limitations |
|---|---|---|---|---|
| Digital CBT-I | Chronic insomnia | Randomized trials, meta-analyses | Insomnia severity, sleep onset | Dropout, short follow-up |
| CPAP with remote monitoring | Obstructive sleep apnea | Randomized and observational | Adherence, symptoms | Adherence varies |
| Wearable apnea notification | Apnea screening | Validation studies | Sensitivity, specificity | Not diagnostic |
| Vestibular stimulation | Insomnia | Small trials | Sleep measures | Limited independent data |
Privacy, Accuracy and Consumer Protection
Sleep data are health-adjacent and sensitive. They can reveal routines, relationships, mental health and location patterns. Consumers should read how companies handle consent, third-party sharing, retention and deletion. Cybersecurity practices vary, and data held by companies that are not covered by HIPAA face fewer federal protections.
Accuracy limits also matter. False alerts can cause anxiety, while missed events can give false reassurance. Measurement error is expected in consumer devices.
Medical claims require authorization. In the US, the FDA clears or authorizes medical devices through pathways such as 510(k) and De Novo. The European Union uses CE marking under its Medical Device Regulation. A device marketed for wellness can avoid those requirements, which is why feature-level regulatory status needs to be read carefully.
The Future of Global Sleep Technology
Multimodal sensors may combine heart, breathing, temperature and brain-related signals. AI could support sleep care by triaging patients for testing, and remote monitoring could help clinicians manage chronic sleep disorders. Circadian-focused tools, such as light therapy and timing recommendations, may become more personalized.
Integration into primary care and workplace health programs is plausible. Employers and health plans already pay for digital CBT-I and apnea screening programs.
Research gaps are significant. Long-term clinical outcome data are scarce, independent validation is limited and access remains uneven. More detailed measurement does not automatically mean better sleep, and the best proven tools remain consistent schedules, treatment of sleep disorders and CBT-I.
Frequently Asked Questions
Q: What are sleep technology companies?
A: Sleep technology companies make wearables, smart beds, respiratory devices, diagnostic tools and digital therapy programs. Some products are consumer gadgets, while others are regulated medical devices. The category spans wellness and clinical care.
Q: How accurate are sleep tracking devices?
A: Consumer devices are fairly good at estimating total sleep time but less accurate for sleep stages. Agreement with polysomnography is moderate for deep and REM sleep. They are best used for trends, not diagnosis.
Q: Can smartwatches detect sleep apnea?
A: Some smartwatches have FDA authorization to flag signs of moderate to severe sleep apnea. They are screening tools, not diagnostic ones. A positive result should lead to a clinical evaluation.
Q: What is the difference between consumer sleep tracking and a sleep study?
A: A sleep study measures brain activity, breathing, oxygen and heart rhythm and is interpreted by clinicians. Consumer tracking estimates sleep from pulse and motion. Only a clinical study can diagnose most sleep disorders.
Q: How does AI improve sleep monitoring?
A: AI models recognize patterns in sensor data, estimate sleep stages and personalize suggestions. Their value depends on training data and validation. Automated advice should not replace clinical guidance.
Q: Can sleep technology help people with insomnia?
A: Digital CBT-I has good evidence for improving insomnia. Wearables alone have not been shown to treat insomnia and may worsen worry in some users. Persistent insomnia warrants a clinician visit.
Q: Are sleep tracking devices safe for personal health data?
A: Safety depends on the company. Consumers should review privacy policies, sharing practices and deletion options. Data outside HIPAA-covered settings may have fewer legal protections.
Q: What is the future of sleep technology?
A: Expect better sensors, AI-assisted triage, remote monitoring and tighter links to healthcare. Clinical validation and independent studies will determine which tools prove useful.